Follow
Yin Huang
Title
Cited by
Cited by
Year
Time‐Dose‐Response Models for Microbial Risk Assessment
Y Huang, CN Haas
Risk Analysis 29 (5), 648-661, 2009
502009
Animal and Human Dose‐Response Models for Brucella Species
SS Teske, Y Huang, SB Tamrakar, TA Bartrand, MH Weir, CN Haas
Risk Analysis 31 (10), 1576-1596, 2011
332011
Development and validation of a treatment benefit index to identify hospitalized patients with COVID-19 who may benefit from convalescent plasma
H Park, T Tarpey, M Liu, K Goldfeld, Y Wu, D Wu, Y Li, J Zhang, ...
JAMA network open 5 (1), e2147375-e2147375, 2022
312022
Incorporating time postinoculation into a dose–response model of Yersinia pestis in mice
Y Huang, TA Bartrand, CN Haas, MH Weir
Journal of applied microbiology 107 (3), 727-735, 2009
282009
Prioritizing risks and uncertainties from intentional release of selected Category A pathogens
T Hong, PL Gurian, Y Huang, CN Haas
PloS one 7 (3), 2012
232012
Dose–response time modelling for highly pathogenic avian influenza A (H5N1) virus infection
M Kitajima, Y Huang, T Watanabe, H Katayama, CN Haas
Letters in applied microbiology 53 (4), 438-444, 2011
202011
Quantification of the relationship between bacterial kinetics and host response for monkeys exposed to aerosolized Francisella tularensis
Y Huang, CN Haas
Applied and environmental microbiology 77 (2), 485-490, 2011
162011
How sensitive is safe? Risk-based targets for ambient monitoring of pathogens
Y Huang, T Hong, TA Bartrand, PL Gurian, CN Haas, R Liu, SB Tamrakar
IEEE Sensors Journal 10 (3), 668-673, 2010
132010
A modified dose–response model that describes the relationship between haemagglutination inhibition titre and protection against influenza infection
Y Huang, SA Anderson, RA Forshee, H Yang
Journal of applied microbiology 124 (1), 294-301, 2018
82018
Geographic exposure risk of variant Creutzfeldt‐Jakob disease in US blood donors: a risk‐ranking model to evaluate alternative donor‐deferral policies
H Yang, Y Huang, L Gregori, DM Asher, T Bui, RA Forshee, SA Anderson
Transfusion 57 (4), 924-932, 2017
82017
Dose‐Response Models Incorporating Aerosol Size Dependency for Francisella tularensis
SS Teske, MH Weir, TA Bartrand, Y Huang, SB Tamrakar, CN Haas
Risk Analysis 34 (5), 911-928, 2014
82014
Early administration of COVID‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy
A Belov, Y Huang, CH Villa, BI Whitaker, R Forshee, SA Anderson, A Eder, ...
American Journal of Hematology 97 (6), 770-779, 2022
72022
Development of Dose-Response Models of Creutzfeldt-Jakob Disease Infection in Nonhuman Primates for Assessing the Risk of Transfusion-Transmitted Variant Creutzfeldt-Jakob Disease
Y Huang, L Gregori, SA Anderson, DM Asher, H Yang
Journal of virology 88 (23), 13732-13736, 2014
62014
Dose-response model of murine typhus (Rickettsia typhi): time post inoculation and host age dependency analysis
SB Tamrakar, Y Huang, SS Teske, CN Haas
BMC infectious diseases 12 (1), 2012
52012
Assessment of risk of variant creutzfeldt‐Jakob disease (vCJD) from use of bovine heparin
Y Huang, RA Forshee, D Keire, S Lee, L Gregori, DM Asher, C Bett, ...
Pharmacoepidemiology and drug safety 29 (5), 575-581, 2020
32020
Incorporating time to response into dose-response models used in quantitative microbial risk assessment
Y Huang
Dissertation Abstracts International 71 (10), 2010
32010
Modeling the Dose Response Relationship of Waterborne Acanthamoeba
K Dean, S Tamrakar, Y Huang, JB Rose, J Mitchell
Risk Analysis 41 (1), 79-91, 2021
22021
A risk assessment model for transfusion transmission of dengue
Y Huang, RA Forshee, R Fares‐Gusmao, C Chancey, M Rios, ...
Letters in Applied Microbiology 75 (5), 1330-1335, 2022
12022
Comparison of hemagglutination inhibition and hemagglutinin pseudovirus neutralization titres in relation to protection against influenza in a mouse model
Y Huang, Z Lin, W Wang, C Weiss, H Xie, RA Forshee
Letters in Applied Microbiology 73 (3), 294-299, 2021
2021
Geographic Risk Evaluation and Assessment Tool (GREAT): Model for Transfusion Transmitted Infectious Diseases
K Chada, Y Huang, C Lane, G Zhang, M Walderhaug, H Yang
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 611-612, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20